Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Nanotechnol.

Sec. Biomedical Nanotechnology

Volume 7 - 2025 | doi: 10.3389/fnano.2025.1639506

This article is part of the Research TopicNanotechnology Advances in Material Processing for Transformative Biomedical ApplicationsView all articles

Nanotechnology advances for biomedical applications

Provisionally accepted
Lekshmi  GangadharLekshmi Gangadhar1*Saranyadevi  SSaranyadevi S2
  • 1NanoDot Research Private Limited, Nagarcoil, India
  • 2Karpagam Academy of Higher Education, Coimbatore, India

The final, formatted version of the article will be published soon.

Nanotechnology has recently emerged as a revolutionary force in the field of biomedical science, offering innovative solutions to complex challenges in diagnostics, drug delivery, tissue engineering, and disease therapeutics. The current sources of nanotechnology and their implications on biomedical applications have been discussed in this review. Nanomaterials are widely used in medical applications because these materials possess some peculiar physicochemical properties. Particularly in cancer, infectious diseases, and chronic diseases, because of its size, available surface area, and responsive surface, it has enhanced therapies, better medication delivery, and superior targeting of medications. Nanotechnology allows the design of drug delivery systems that have advanced carriers that release drug formulations in response to specific stimuli in the neighborhood. Nanotechnology has also increasingly contributed to early disease diagnosis by combining it with diagnostic equipment. These innovations have prophesied non-invasive diagnostics that accelerate and enhance the diagnosis of diseases at the molecular level. Regenerative medicine has benefited from nanotechnology through the design of nano scaffolds that promote tissue regeneration and support stem cell therapies. In addition, the start of the application of nanomaterials in immunotherapy has provided novel directions in the development of antigen-directed vaccines and immune modulation. Despite the vast potential, the translation of nanotechnological innovations from laboratory research to clinical applications encounters difficulties with cost, safety, adaptability, and approval from regulatory bodies. In addition, the review addresses the potential future paths of nanotechnology in biomedicine, including the integration of artificial intelligence, the development of multifunctional nanodevices, and the promise of theranostics. Nanotechnology has the enormous possibility to transform healthcare in the future by offering accurate, individualized, and successful therapies for a variety of illnesses.

Keywords: biomedicine, drug delivery system, Immunotherapy, Nanoparticles, Regenerative Medicine

Received: 02 Jun 2025; Accepted: 06 Oct 2025.

Copyright: © 2025 Gangadhar and S. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lekshmi Gangadhar, lekshmigangadhar.nano@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.